[Use of rifadin in suppositories in the combined therapy of patients with destructive forms of pulmonary tuberculosis].
D000328:Adult; D000368:Aged; D000995:Antitubercular Agents / Q000008:administration & dosage* / Q000378:metabolism; D001682:Biological Availability; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000008:administration & dosage* / Q000378:metabolism; D013488:Suppositories; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000150:complications / Q000188:drug therapy*
D000995:Antitubercular Agents; D013488:Suppositories; D012293:Rifampin
Primenenie rifadina v svechakh v kompleksnoĭ terapii bol'nykh s destruktivnymi formami tuberkuleza legkikh.